Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Immune Response Against Viral Pathogens

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

Vaccinations

Vaccinations

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

Vaccines

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

T Cell Activation and Clonal Selection

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Macrophage CD14 impacts immune defenses against influenza virus in allergic hosts.

Microbial pathogenesis·2018

Same author

The immune profile associated with acute allergic asthma accelerates clearance of influenza virus.

Immunology and cell biology·2014

Same author

Cross-talk between programmed death-1 and suppressor of cytokine signaling-1 in inhibition of IL-12 production by monocytes/macrophages in hepatitis C virus infection.

Journal of immunology (Baltimore, Md. : 1950)·2011

Same author

PD-1 modulates regulatory T cells and suppresses T-cell responses in HCV-associated lymphoma.

Immunology and cell biology·2010

Same author

Heterologous CD8 T cell immune response to HSV induced by toll like receptor ligands.

Cellular immunology·2009

Same author

T regulatory cells: an overview and intervention techniques to modulate allergy outcome.

Clinical and molecular allergy : CMA·2009

Search research articles

Related Experiment Video

Updated: Jun 14, 2026

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus

Published on: May 7, 2012

Viral vaccines and CTL response.

Stacie N Woolard¹, Uday Kumaraguru

¹Department of Microbiology, Quillen College of Medicine, East Tennessee State University, Johnson City, TN 37614, USA.

Journal of Biomedicine & Biotechnology

|April 10, 2010

Summary

This summary is machine-generated.

Successful vaccines stimulate both arms of immunity. This review focuses on CD8+ cytotoxic T lymphocytes (CTLs), crucial for fighting intracellular infections and tumors, and suggests improved vaccine designs for CTL induction.

More Related Videos

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

Related Experiment Videos

Last Updated: Jun 14, 2026

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus

Published on: May 7, 2012

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

Area of Science:

Immunology
Vaccinology
Cellular Immunity

Background:

Effective vaccines typically engage both humoral and cellular immune responses.
CD8+ cytotoxic T lymphocytes (CTLs) are vital for controlling intracellular pathogens and tumors.
MHC class I expression on all tissues facilitates CTL-mediated pathogen clearance.

Purpose of the Study:

To review immune induction mechanisms of successful vaccines.
To explore the significance of CD8+ CTLs in immunity.
To propose strategies for designing enhanced CTL-inducing vaccines.

Main Methods:

Literature review of vaccine immunology.
Analysis of mechanisms underlying CTL induction.
Synthesis of evidence for vaccine design improvement.

Main Results:

Successful vaccines activate both B cell (humoral) and T cell (cellular) immunity.
CD8+ CTLs play a critical role in combating intracellular infections and cancer.
Vaccine strategies can be optimized to specifically induce robust CTL responses.

Conclusions:

Targeting CD8+ CTL induction is a promising approach for vaccines against challenging pathogens.
Understanding immune induction pathways can lead to more effective vaccine formulations.
Further research into CTL-inducing vaccines holds potential for improved disease prevention.